David Nemazee

Title: David Nemazee: Innovator in Immune Tolerance

Introduction

David Nemazee is a prominent inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly in the area of inducing immune tolerance. With a total of two patents to his name, Nemazee's work is paving the way for advancements in therapeutic methods.

Latest Patents

Nemazee's latest patents focus on compositions and methods for inducing immune tolerance. The first patent presents liposomal compositions designed to induce immune tolerance. These compositions typically comprise a liposome that displays a specific antigen along with a binding moiety for a sialic acid binding Ig-like lectin (Siglec) expressed on B cells. The invention also outlines methods for inducing tolerance to a protein or polypeptide antigen in a subject. This involves administering a pharmaceutical composition that co-presents both the antigen and a glycan ligand for a Siglec expressed on B lymphocytes.

Career Highlights

David Nemazee is affiliated with The Scripps Research Institute, where he continues to explore innovative solutions in immunology. His research has garnered attention for its potential applications in treating various immune-related conditions.

Collaborations

Some of Nemazee's notable coworkers include James C. Paulson and Matthew MacAuley. Their collaborative efforts contribute to the advancement of research in the field of immune tolerance.

Conclusion

David Nemazee's work in the field of immunology, particularly through his patents on inducing immune tolerance, showcases his innovative spirit and dedication to advancing medical science. His contributions are likely to have a lasting impact on therapeutic approaches in immunology.